Effects of selegiline on cognitive functions in normal subjects using fMRI
Not Applicable
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000012904
- Lead Sponsor
- ippon Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 7
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects with drug allergy, heart and cerebral circulatory disturbance, pheochromocytoma, glaucoma, liver and renal dysfunction, hypertension, diabetes mellitus. Subjects taking drugs within 2 weeks of the trial. Subjects with contraindications to MRI. Subjects who are judged as not suitable for participation in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method